
COURSE DIRECTORS

Mack Mitchell, MD
Vice President for Medical Affairs
University of Texas Southwestern Medical Center
Dallas, Texas

Lawrence Schiller, MD
Chair, Institutional Review Boards
Baylor University Medical Center
Dallas, Texas
ADDITIONAL FACULTY WILL BE ANNOUNCED SOON!
Friday, May 16, 2025
11:45 AM
Lunch and Registration
12:00 PM - 12:45 PM
Industry-Sponsored Event (Non-accredited)
Sponsored by Eli Lilly & Company
12:50 PM - 1:05 PM
Welcome
Session I
1:05 PM - 1:30 PM
Artificial Intelligence in the Clinic and Endoscopy Laboratory
1:30 PM - 1:55 PM
Microbiome Therapeutics
​
​
1:55 PM - 2:20 PM
Managing the Obesity Epidemic
2:20 PM - 2:35 PM
Q&A / Panel Discussion
2:35 PM – 2:50 PM
Break
Session II
​
2:50 PM - 3:15 PM
New and Emerging Treatments for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
​
3:15 PM - 3:40 PM
A New Category of Steatotic Liver Disease—MetALD
(Is it Alcohol or Metabolic?)
Mack Mitchell, MD
​
3:40 PM - 4:05 PM
Updates on the Management of Hepatocellular Carcinoma
​
​
4:05 PM - 4:30 PM
Q&A / Panel Discussion
​
4:30 PM – 5:30 PM
Major Advancement in MASH Management
Sponsored by Johnson & Johnson
5:30 PM - 7:00 PM
Reception
​
Saturday, May 17, 2025
​
7:15 AM
Breakfast and Registration
​
7:30 AM - 8:15 AM
Industry-Sponsored Event (Non-accredited)
Sponsored by Madrigal
​
8:20 AM – 8:25 AM
Welcome Back
​
Session III
8:25 AM – 8:55 AM
Diagnosis and Management of Cyclic Vomiting Syndrome and Cannabis Hyperemesis Syndrome
Lawrence Schiller, MD
8:55 AM - 9:25 AM
Helicobacter Pylori
9:25 AM - 9:55 AM
Integrating Potassium-competitive Acid Blockers (PCABs) Into Clinical Practice
​
​
9:55 AM - 10:20 AM
Q&A / Panel Discussion
10:20 AM – 10:35 AM
Break
10:35 AM - 11:35 AM
Parallel Session (Select One)
-
GI Woes from Head to Toe
-
Inflammatory Bowel Disease
-
Obesity and Steatosis
-
Chronic Liver Disease
11:35 AM - 11:50 AM
Lunch Break
11:50 AM - 12:35 PM
Industry-Sponsored Event (Non-accredited)
Sponsored By Regeneron
​
Session IV
12:35 PM - 1:05 PM
Current Updates in the Management of Primary Biliary Cholangitis (PBC)
​
1:05 PM - 1:35 PM
Acute-on-Chronic Liver Failure and the Management of Critically Ill Patients With Cirrhosis
​
1:35 PM - 2:00 PM
Risk Stratification and Management of Portal Hypertension and Varices in Cirrhosis:
Understanding the New AASLD Practice Guidance
​
2:00 PM - 2:25 PM
Update on Hepatitis B, Including Hepatitis D
2:25 PM - 2:40 PM
Q&A / Panel Discussion
2:40 PM - 2:50 PM
Break
Session V
2:50 PM - 3:20 PM
Management of Moderate to Severe Inflammatory Bowel Disease (IBD)
3:20 PM - 3:50 PM
Diet & Nutritional Therapy for IBD
​​
3:50 PM - 4:20 PM
Intestinal Ultrasound for the Management of IBD
4:20 PM - 4:35 PM
Q&A / Panel Discussion
4:35 PM - 4:45 PM
Meeting Wrap-up
This activity is jointly provided by the Annenberg Center for Health Sciences at Eisenhower, the Gastrointestinal and Liver Association of the Americas, and the Texas Liver Institute.


